Addition Therapeutics, Inc.

CIK 2102340 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Addition Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Dec 22, 2025D0002102340-25-000001